These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6339173)

  • 1. Nonspecific host defenses in surgical cancer patients.
    Howard RJ
    Curr Probl Cancer; 1983 Feb; 7(8):1-39. PubMed ID: 6339173
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormalities of cell-mediated immunocompetence in genitourinary cancer.
    Catalona WJ; Chretien PB; Trahan EE
    J Urol; 1974 Feb; 111(2):229-32. PubMed ID: 4855735
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum ribonuclease in urologic cancer. Relation to host immunocompetence.
    Catalona WJ; Chretien PB; Matthews WJ; Tarpley JL
    Urology; 1973 Nov; 2(5):577-81. PubMed ID: 4797457
    [No Abstract]   [Full Text] [Related]  

  • 4. Predicting infection in surgical patients.
    Pietsch JB; Meakins JL
    Surg Clin North Am; 1979 Apr; 59(2):185-97. PubMed ID: 375442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host factors in bacteremia.
    Cates KL
    Am J Med; 1983 Jul; 75(1B):19-25. PubMed ID: 6224418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology of genitourinary tumors.
    Guinan P; Sadoughi N; Bush IM; John T; Eghrari F; Ablin RJ
    Urology; 1973 Nov; 2(5):493-9. PubMed ID: 4131868
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotherapy in genitourinary neoplasia.
    Droller MJ
    J Urol; 1985 Jan; 133(1):1-5. PubMed ID: 2578065
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic features of genitourinary cancer.
    Javadpour N
    Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunobiologic defense -- the view of the surgeon.
    Eiseman B
    Ann Chir Gynaecol; 1977; 66(2):63-71. PubMed ID: 301374
    [No Abstract]   [Full Text] [Related]  

  • 10. Need for immunologic stimulators during immunosuppression produced by major cancer surgery.
    Cole WH; Humphrey L
    Ann Surg; 1985 Jul; 202(1):9-20. PubMed ID: 3893336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunology of malignant neoplasms of the urogenital system].
    Stratev S
    Khirurgiia (Sofiia); 1988; 41(1):46-52. PubMed ID: 3285081
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic competence in patients with urologic cancer.
    McLaughlin AP; Kessler WO; Triman K; Gittes RF
    J Urol; 1974 Feb; 111(2):233-7. PubMed ID: 4272638
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of alpha-globulin as a biological tracer in urogenital cancer].
    Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA
    Actas Urol Esp; 1978; 2(3):119-26. PubMed ID: 79304
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations of host defenses: the key to the multifaceted spectrum of infections in immunocompromised patients.
    Glauser MP
    Recent Results Cancer Res; 1991; 121():321-8. PubMed ID: 1857870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HL-A antigens in solid tumors.
    Takasugi M; Terasaki PI; Henderson B; Mickey MR; Menck H; Thompson RW
    Cancer Res; 1973 Apr; 33(4):648-50. PubMed ID: 4739655
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH; Castro A; Elliott A; Fraley EE
    Cancer; 1974 Dec; 34(6):1929-34. PubMed ID: 4434325
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic exploration of cancer patients. 1. Nontumoral immunity].
    Cappelaere P; Adenis L; Demaille A
    Lille Med; 1973 Jun; 18(1):96-112. PubMed ID: 4352336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P; Demaille A; Adenis L
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunostaging: comment and update.
    Ablin RJ
    Allergol Immunopathol (Madr); 1980; 8(6):685-8. PubMed ID: 7193968
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte stimulation in urologic cancer patients.
    Catalona WJ; Tarpley JL; Chretien PB; Castle JR
    J Urol; 1974 Sep; 112(3):373-7. PubMed ID: 4859402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.